THE MAG
Summer 2017

CRISPRed crops and agbiotech’s future

In this issue:

  • Bioeconomy: Uncertainty about review of EU strategy hampers investments
  • Orphan Drugs: How can healthcare systems establish value-based pricing?
  • Allergies New biotech solutions target oversensitive immune systems
  • Biofairs Compass: Your guide to relevant EU life sciences events in H2/2017
  • Focus Biomanufacturing: Bright future for biomanufacturers
  • Interviews with Federico Pollano, Business Development & Contract Manufacturing Director, Polpharma and Daniel Oliver, CEO, Capital Cell, Barcelona
  • News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association

Spring 2017